PHYSIOLOGICALLY-BASED PHARMACOKINETIC ANALYSES OF SIMPLE MIXTURES

被引:33
|
作者
KRISHNAN, K
CLEWELL, HJ
ANDERSEN, ME
机构
[1] UNIV MONTREAL,FAC MED,DEPT MED TRAVAIL & HYG MILIEU,MONTREAL,PQ,CANADA
[2] CHEM IND INST TOXICOL,RES TRIANGLE PK,NC
[3] MANTECH ENVIRONM TECHNOL INC,DAYTON,OH
关键词
PHYSIOLOGICAL PHARMACOKINETICS; PBPK MODELING; CHEMICAL MIXTURES; TOXICOKINETIC INTERACTION;
D O I
10.1289/ehp.94102s9151
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Exposure to multiple chemicals may cause significant alterations of tissue dose of the toxic moiety of one or more of the individual chemicals. The change in target tissue dose of a chemical present in simple mixtures can be predicted when the determinants of disposition of each chemical, and the mechanism of toxicokinetic interaction between chemicals are understood at a quantitative level. Determinants of disposition include physiological (e.g., breathing rates, cardiac output, tissue volumes, blood flow rates), biochemical (e.g., kinetic constants for metabolism and protein binding), and physicochemical factors (e.g., blood:air and tissue:blood partition coefficients). Mechanisms of toxicokinetic interactions refer to the manner in which coexposure alters these determinants of disposition as compared to exposure to the individual chemicals. Interactions between chemicals can be described quantitatively with physiologically based pharmacokinetic (PBPK) models, which integrate these mechanistic determinants and permit prediction of alterations in tissue dose for various exposure situations by computer simulation. PBPK modeling studies of binary chemical interactions conducted so far indicate that inhibitory rather than potentiating metabolic interactions are more likely to be observed during multiple chemical exposures. As PBPK models of representative binary, tertiary and quaternary mixtures are developed, it will become increasingly possible to draw reliable conclusions about the risk associated with human exposure to chemical mixtures.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 50 条
  • [41] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF A MIXTURE OF TOLUENE AND XYLENE IN HUMANS
    TARDIF, R
    LAPARE, S
    CHARESTTARDIF, G
    BRODEUR, J
    KRISHNAN, K
    RISK ANALYSIS, 1995, 15 (03) : 335 - 342
  • [42] Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
    Miroslav Dostalek
    Iain Gardner
    Brian M. Gurbaxani
    Rachel H. Rose
    Manoranjenni Chetty
    Clinical Pharmacokinetics, 2013, 52 : 83 - 124
  • [43] Physiologically-based pharmacokinetic (PBPK) model to describe the disposition of pyronaridine
    Diep, John K.
    Lingerfelt, Mary A.
    Ekins, Sean
    Rao, Gauri G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S34 - S34
  • [44] Adapting physiologically-based pharmacokinetic models for machine learning applications
    Habiballah, Sohaib
    Reisfeld, Brad
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] Physiologically-based pharmacokinetic modeling of benzene in humans: A Bayesian approach
    Yokley, Karen
    Tran, Hien T.
    Pekari, Kaija
    Rappaport, Stephen
    Riihimaki, Vesa
    Rothman, Nat
    Waidyanatha, Suramya
    Schlosser, Paul M.
    RISK ANALYSIS, 2006, 26 (04) : 925 - 943
  • [46] Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine
    Hartmanshenn, Clara
    Scherholz, Megerle
    Androulakis, Ioannis P.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 (05) : 481 - 504
  • [47] Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine
    Clara Hartmanshenn
    Megerle Scherholz
    Ioannis P. Androulakis
    Journal of Pharmacokinetics and Pharmacodynamics, 2016, 43 : 481 - 504
  • [48] Physiologically-based pharmacokinetic model for 2,4-dinitrophenol
    Lyndsey F. Meyer
    Pooja M. Rajadhyaksha
    Dhaval K. Shah
    Journal of Pharmacokinetics and Pharmacodynamics, 2022, 49 : 325 - 336
  • [49] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR DESETHYLAMIODARONE
    HOU, ZY
    BALTER, NJ
    WOOSLEY, RL
    SCHWARTZ, SL
    CIRCULATION, 1990, 82 (04) : 196 - 196
  • [50] Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats
    Ai, Jing
    Gao, Yunfeng
    Yang, Fan
    Zhao, Zhen
    Dong, Jin
    Wang, Jing
    Fu, Shiyi
    Ma, Ying
    Gu, Xu
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11